000 02109 a2200709 4500
005 20250517124159.0
264 0 _c20171009
008 201710s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/leu.2016.334
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFritsch, K
245 0 0 _aHigh-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).
_h[electronic resource]
260 _bLeukemia
_c04 2017
300 _a846-852 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aCentral Nervous System Neoplasms
_xdiagnosis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xadministration & dosage
650 0 4 _aLymphoma
_xdiagnosis
650 0 4 _aMale
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aNeoplasm Staging
650 0 4 _aProportional Hazards Models
650 0 4 _aQuality of Life
650 0 4 _aRemission Induction
650 0 4 _aTreatment Outcome
650 0 4 _aTumor Burden
700 1 _aKasenda, B
700 1 _aSchorb, E
700 1 _aHau, P
700 1 _aBloehdorn, J
700 1 _aMöhle, R
700 1 _aLöw, S
700 1 _aBinder, M
700 1 _aAtta, J
700 1 _aKeller, U
700 1 _aWolf, H-H
700 1 _aKrause, S W
700 1 _aHeß, G
700 1 _aNaumann, R
700 1 _aSasse, S
700 1 _aHirt, C
700 1 _aLamprecht, M
700 1 _aMartens, U
700 1 _aMorgner, A
700 1 _aPanse, J
700 1 _aFrickhofen, N
700 1 _aRöth, A
700 1 _aHader, C
700 1 _aDeckert, M
700 1 _aFricker, H
700 1 _aIhorst, G
700 1 _aFinke, J
700 1 _aIllerhaus, G
773 0 _tLeukemia
_gvol. 31
_gno. 4
_gp. 846-852
856 4 0 _uhttps://doi.org/10.1038/leu.2016.334
_zAvailable from publisher's website
999 _c26603150
_d26603150